Founder mutations in the BRCA1 gene polish families with breast-ovarian cancer

American Journal of Human Genetics

Volumn 66, Issue 6, 2000, Pages 1963-1968

  Gorski B ^a   Byrski, T ^a   Huzarski, T ^a   Jakubowska, A ^a   Menkiszak, J ^b   Gronwald, J ^a   Pluzanska A ^c   Bebenek M ^d   Fischer Maliszewska, L ^e   Grzybowska, E ^f   Narod, S A ^g   Lubinski J ^a  

^a International Hereditary Cancer Center   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c Department of Oncology   (Poland)

^d Oncological Center   (Poland)

^e INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^f INSTITUTE OF ONCOLOGY   (Poland)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; DNA DETERMINATION; FEMALE; GENE MUTATION; HIGH RISK POPULATION; HUMAN; ONCOGENE; OVARY CANCER; POLAND; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0033939978     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302922     Document Type: Article

References (35)

1. Andersen T, Børresen A-L, Møller P (1996) A common BRCA1 mutation in Norwegian breast and ovarian cancer families? Am J Hum Genet 59:486-487
2. Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, et al (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13:123-125
3. Couch FJ, Weber BL (1996) Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum Mutat 8:8-18
4. Csokay B, Tihomirova L, Stengrevics A, Sinicka O, Olah E (1999) Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia: mutation in brief no. 258. Online. Hum Mutat 14:92
5. Dorum A, Hovig E, Trope C, Inganas M, Moller P (1999) Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA. Eur J Cancer 35:779-781
6. Dorum A, Moller P, Kamsteeg EJ, Scheffer H, Burton M, Heimdal KR, Maehle LO, et al (1997) A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing. Eur J Cancer 33:2390-2392
7. Easton DF, Ford D, Bishop DT, the Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271
8. Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder PA, et al (1997) Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60:313-319
9. Futreal PA, Liu QY, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, et al (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122
10. Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF, Ponder BAJ (1997) Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am J Hum Genet 60:1239-1242
11. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, et al (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 11:428-433
12. Håkansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes A-M, Holmberg E, et al (1997) Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 60: 1068-1078
13. Jakubowska A, Gronwald J, Huzarski T, Byrski T, Menkiszak J, Lubinski J (1999) Human gene mutations. Hum Genet 105:293
14. Johannsson O, Ostermeyer EA, Håkansson S, Friedman LS, Johansson U, Sellberg G, Brøndum-Nielsen K, et al (1996) Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet 58:441-450
15. Lahiri DK, Nurnberger JI Jr (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444
16. Mazoyer S, Dunning AM, Serova O, Dearden J, Puget N, Healey CS, Gayther SA, et al (1996) A polymorphic stop codon in BRCA2. Nat Genet 14:253-254
17. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu QY, et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
18. Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, et al (1996) Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13:126-128
19. Peelen T, van Vliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland AMW, Hogervorst F, et al (1997) A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60:1041-1049
20. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, et al (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943-949
21. Petrij-Bosch A, Peelen T, van Vliet M, van Eijk RV, Olmer R, Drusedau M, Hogervorst FB, et al (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341-345
22. Ramus SJ, Kote-Jarai Z, Friedman LS, van der Looij M, Gayther SA, Csokay B, Ponder BAJ, et al (1997) Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. Am J Hum Genet 60:1242-1246
23. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467
24. Santarosa M, Viel A, Dolcetti R, Crivellari D, Magri MD, Pizzichetta MA, Tibiletti MG, et al (1998) Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancer. Int J Cancer 78:581-586
25. Simard J, Tonin P, Durocher F, et al (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8:392-398
26. Sobczak K, Kozlowski P, Napierala M, Czarny J, Wozniak M, Kapuscinska M, Losko M, et al (1997) Novel BRCA1 mutations and more frequent intron-20 alteration found among 236 women from Western Poland. Oncogene 15:1773-1779
27. Streuwing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (1995) The carrier frequency of the BRCA1 185delAG mutatiom is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198-200
28. Streuwing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408
29. Szabo CI, King M-C (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013-1020
30. Thorlacius S, Olafsdottir S, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, et al (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13: 117-121
31. Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H, et al (1997) Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60:1079-1084
32. Tonin P, Serova O, Lenoir G, Lynch H, Durocher F, Simard J, Morgan K, et al (1995) BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet 57:189
33. Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, et al (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2:1179-1183
34. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, et al (1995) Identification of the breast cancer gene BRCA2. Nature 378:789-792
35. Wooster R, Neuhausen S, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, et al (1994) Location of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090